AI in Breast Cancer Stem Cells and Proteomics

Dr. Manzoor Ahmad Mir holds a Master's in Zoology from HNBG Central University and completed his Ph.D. in Immunology at Jawaharlal Nehru University, New Delhi, and CSIR-Institute of Microbial Technology, Chandigarh. His research focuses on cancer biology, combination therapy in breast cancer, and tuberculosis immunology. Dr. Mir has published over 50 high-impact research papers and book chapters. He has authored more than 15 books with international publishers of repute. He serves on the editorial boards of prestigious journals. He is a member of several scientific organizations, including the American Association of Cancer Research and the Royal British Society. He has received the TARE Fellowship and the SRFP-2019 from the Indian Science Academies. Dr. Mir teaches Cancer Biology and Immunology at the University of Kashmir, where he heads the Department of Bioresources. Dr. Hina Qayoom is an accomplished researcher and academic currently serving as Assistant Professor in the Department of Bioresources, School of Biological Sciences, Amar Singh College, Cluster University, Jammu & Kashmir. She earned her Ph.D. in Bioresources from the University of Kashmir, specializing in Cancer Biology, where her research centered on targeting breast cancer using natural compounds with anti-cancer potential. Her doctoral work, acclaimed internationally, was selected for presentation at the prestigious ASCO 2024 Conference and published in the Journal of Clinical Oncology (Impact Factor 45.3). With over 78 peer-reviewed publications, an H-index of 18, and numerous articles in high-impact journals such as Cell Communication and Signaling, Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, and Critical Reviews in Oncology/Hematology, Dr. Qayoom has made significant contributions to understanding breast cancer pathogenesis, stemness, and therapy resistance. Her work explores some of the most challenging aspects of cancer progression and therapy resistance, contributing significantly to the advancement of targeted cancer therapeutics.

• 1. Introduction to Breast Cancer Stem Cells and Tumor Heterogeneity2. Breast Cancer Stem Cells Across Subtypes: Biology, Challenges and Recent Advances3. Proteomics in Breast Cancer: Technologies and Applications4. Foundations of Artificial Intelligence in Biomedical Research5. AI for Stem Cell Characterization, Imaging and Diagnostics6. Proteomic Biomarkers and AI-Based Predictive Models7. AI for Drug Resistance and Therapy Response Prediction in BCSCs8. Multi-Omics Integration Using AI: From Bench to Bedside9. Interface between BCSCs and Immunotherapy: Implications for personalized medicine with case studies10. Future Directions: Smart Oncology and Personalized Medicine”